Home › Leucemia linfoblastica acuta › Ohio › Cincinnati
Studi clinici su Leucemia linfoblastica acuta a Cincinnati, OH
12 studi su Leucemia linfoblastica acuta cercano partecipanti presso sedi a Cincinnati e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- e altri 3
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
In reclutamentoStudio osservazionale
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
In reclutamentoFase 2
- Oncology Hematology Care, Cincinnati
- Cincinnati Children's Hospital Medical Center, Cincinnati
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
In reclutamentoFase 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
In reclutamentoFase 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
In reclutamentoFase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
In reclutamentoStudio osservazionale
- Children's Hospital Medical Center, Cincinnati
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
In reclutamentoStudio osservazionale
- Cincinnati Children's Hospital, Cincinnati
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
In reclutamentoFase 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
In reclutamentoStudio osservazionale
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
In reclutamentoFase 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University of Cincinnati, Cincinnati
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
In reclutamentoFase 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
Studi su Leucemia linfoblastica acuta in altre città
- Houston, TX28 studi
- New York City, NY24 studi
- Baldwin Park, CA21 studi
- Seattle, WA21 studi
- Chicago, IL19 studi
- Atlanta, GA19 studi
- Philadelphia, PA16 studi
- Memphis, TN16 studi
- Washington, DC16 studi
- Boston, MA15 studi
- Los Angeles, CA14 studi
- Durham, NC13 studi
Altri studi a Cincinnati
- Cancro del polmone non a piccole cellule35 studi
- Cancro (tutti i tipi)27 studi
- Cancro al seno25 studi
- Insufficienza cardiaca24 studi
- Cancro colorettale21 studi
- Leucemia mieloide acuta20 studi
- Cancro metastatico20 studi
- Cancro ovarico19 studi
- Cancro ai polmoni19 studi
- Obesità19 studi
- Cancro alla prostata18 studi
- Mieloma multiplo17 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.